XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.2
Note 15 - Stockholders' Equity
9 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
1
5
. STOCKHOLDERS’ EQUITY
 
Summary
 
The following table summarizes changes in the components of stockholders’ equity during the
nine
months ended
June 30, 2019
and the
nine
months ended
June 30, 2018:
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated
   
 
 
 
   
 
 
 
 
 
 
 
 
Additional
   
 
 
 
 
Other
   
Total
 
   
Common Stock
   
Paid-in
   
Accumulated
   
Comprehensive
   
Stockholders'
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
Loss
   
Equity
 
Balance at September 30, 2018
   
33,176,146
    $
332
    $
90,251,145
    $
(56,516,895
)   $
(245,375
)   $
33,489,207
 
                                                 
Share-based compensation expense
   
-
     
-
     
133,845
     
-
     
 
     
133,845
 
Issuance of common stock upon exercise of stock options, net
   
1,600
     
-
     
2,528
     
-
     
-
     
2,528
 
Stock buyback
   
(588,425
)    
(6
)    
(1,621,016
)    
-
     
-
     
(1,621,022
)
Other comprehensive loss
   
-
     
-
     
-
     
-
     
(54,335
)    
(54,335
)
Net income
   
-
     
-
     
-
     
1,045,940
     
-
     
1,045,940
 
Balance at December 31, 2018
   
32,589,321
    $
326
    $
88,766,502
    $
(55,470,955
)   $
(299,710
)   $
32,996,163
 
                                                 
Share-based compensation expense
   
-
     
-
     
171,975
     
-
     
-
     
171,975
 
Issuance of common stock upon exercise of stock options, net
   
26,682
     
-
     
42,644
     
-
     
-
     
42,644
 
Issuance of common stock upon vesting of restricted stock units
   
156,115
     
2
     
-
     
-
     
-
     
2
 
Stock buyback
   
(200,000
)    
(2
)    
(549,998
)    
 
     
 
     
(550,000
)
Other comprehensive loss
   
-
     
-
     
-
     
-
     
(69,091
)    
(69,091
)
Net income
   
-
     
-
     
-
     
1,178,850
     
-
     
1,178,850
 
Balance at March 31, 2019
   
32,572,118
    $
326
    $
88,431,123
    $
(54,292,105
)   $
(368,801
)   $
33,770,543
 
                                                 
Share-based compensation expense
   
-
     
-
    $
257,566
    $
-
    $
-
     
257,566
 
Issuance of common stock upon exercise of stock options, net
   
7,000
     
-
     
9,449
     
-
     
-
     
9,449
 
Other comprehensive loss
   
-
     
-
     
-
     
-
     
56,538
     
56,538
 
Net income
   
-
     
-
     
 
     
638,041
     
-
     
638,041
 
Balance at June 30, 2019
   
32,579,118
    $
326
    $
88,698,138
    $
(53,654,064
)   $
(312,263
)   $
34,732,137
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated
   
 
 
 
   
 
 
 
 
 
 
 
 
Additional
   
 
 
 
 
Other
   
Total
 
   
Common Stock
 
 
Paid-in
   
Accumulated
   
Comprehensive
   
Stockholders'
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
Loss
   
Equity
 
Balance at September 30, 2017
   
32,158,436
    $
322
    $
87,956,839
    $
(52,771,853
)   $
(1,269
)   $
35,184,039
 
                                                 
Share-based compensation expense
   
-
     
-
     
138,461
     
-
     
-
     
138,461
 
Issuance of common stock upon exercise of stock options, net
   
90,852
     
-
     
159,518
     
-
     
-
     
159,518
 
Other comprehensive loss
   
-
     
-
     
-
     
-
     
(8,031
)    
(8,031
)
Net income
   
-
     
-
     
-
     
(1,683,252
)    
-
     
(1,683,252
)
Balance at December 31, 2017
   
32,249,288
    $
322
    $
88,254,818
    $
(54,455,105
)   $
(9,300
)   $
33,790,735
 
                                                 
Share-based compensation expense
   
-
     
-
     
145,789
     
-
     
-
     
145,789
 
Issuance of common stock upon exercise of stock options, net
   
20,000
     
-
     
26,200
     
-
     
-
     
26,200
 
Issuance of common stock upon vesting of restricted stock units
   
125,000
     
-
     
-
     
-
     
-
     
-
 
Other comprehensive loss
   
-
     
-
     
-
     
-
     
(4,482
)    
(4,482
)
Net income
   
-
     
-
     
-
     
460,908
     
-
     
460,908
 
Balance at March 31, 2018
   
32,394,288
    $
322
    $
88,426,807
    $
(53,994,197
)   $
(13,782
)   $
34,419,150
 
                                                 
Share-based compensation expense
   
-
     
-
     
148,813
     
-
     
-
     
148,813
 
Issuance of common stock upon exercise of stock options, net
   
468,801
     
5
     
842,001
     
-
     
-
     
842,006
 
Stock buyback
   
(211,326
)    
(2
)    
(500,272
)    
-
     
-
     
(500,274
)
Other comprehensive loss
   
-
     
-
     
-
     
-
     
(211,426
)    
(211,426
)
Net income
   
-
     
-
     
-
     
(80,220
)    
-
     
(80,220
)
Balance at June 30, 2018
   
32,651,763
    $
325
    $
88,917,349
    $
(54,074,417
)   $
(225,208
)   $
34,618,049
 
 
 
 
Share Buyback Program
 
The Board of Directors approved a share buyback program in
2015
under which the Company was authorized to repurchase up to
$4
million of its outstanding common shares. In
December 2017,
the Board of Directors extended the program through
December 31, 2018.
 
In
December 2018,
the Board of Directors approved a new share buyback program beginning
January 1, 2019
and expiring on
December 31, 2020,
under which the Company is authorized to repurchase up to
$5
million of its outstanding common shares exclusive of any fees, commissions or other expenses related to such repurchases. At
June 30, 2019,
$4.5
million was available for share repurchase under this program. The previous program expired on
December 31, 2018.
 
There were
788,425
shares repurchased for
$2,171,022
during the
nine
months ended
June 30, 2019.
There were
211,236
shares repurchased for
$500,274
during the
nine
-month period ended
June 30, 2018.
At
June 30, 2019,
all repurchased shares were retired into treasury.
 
Dividends
 
There were
no
dividends declared in the
nine
months ended
June 30, 2019
and
2018.